Company intelligence / Profile preview

BaroPace

Sammamish/Issaquah/Ashland, Washington, United Statesbaropace.com ↗

Ownership: Private
Development stage: Phase 1

Overview

The Phase I first-in-human RelieveHFpEF-II trial of PressurePace™ met all primary endpoints—improving quality of life and exercise tolerance—and secondary endpoints including improved walk time and NYHA score compared to standard pacing. No adverse events were reported. Clinically meaningful reductions in systolic blood pressure and pulse pressure were observed. Results presented at HRS 2024; US pivotal multicenter trial planned.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftwareHardware
Industry: Implantable Medical Devices

Drug pipeline

1 asset

PressurePace

Phase 1

Indications: Drug resistant hypertension, Heart failure with preserved ejection fraction

Partnerships

Medtronic – benchtop development collaboration for the PressurePace prototype completed in animal models in partnership with Medtronic.

Beyond the preview

Go deeper on BaroPace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BaroPace.

Explore the full profile